Intercept Pharmaceuticals Inc (NASDAQ:ICPT)
| 48.04 Delayed Data As of 3:59pm ET |  +0.49 / +1.03%Today’s Change | 42.19 Today|||52-Week Range 125.00 | -61.23% Year-to-Date |
Latest ICPT News | Press Releases
| Theratechnologies NASH Data And Other News: The Good, Bad And Ugly Of Biopharma Jul 26 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 47.55 |
| Today’s open | 47.59 |
| Day’s range | 47.41 - 49.19 |
| Volume | 20,398 |
| Average volume (3 months) | 865,974 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 08/05/2020
Growth & Valuation
| Earnings growth (last year) | -0.23% |
| Earnings growth (this year) | -1.01% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +40.15% |
| P/E ratio | NM |
| Price/Sales | 15.57 |
| Price/Book | 29.08 |
Competitors
| ---- | ||
| IRWDIronwood Pharmaceuti... | -0.09 | -0.92% |
| AKBAAkebia Therapeutics ... | +0.21 | +1.92% |
| YMABY-mAbs Therapeutics,... | +0.70 | +1.85% |
Data as of 3:59pm ET, 08/05/2020
Financials
| Next reporting date | August 10, 2020 |
| EPS forecast (this quarter) | -$2.88 |
| Annual revenue (last year) | $252.0M |
| Annual profit (last year) | -$344.7M |
| Net profit margin | -136.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
